<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Med | wechat-feeds</title><link>http://MzIwMTk2MDM3Ng.favicon.privacyhide.com/favicon.ico</link><description>Best Evidence, Best Benefit</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 31 Mar 2021 10:05:28 +0800</pubDate><image><url>http://MzIwMTk2MDM3Ng.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Med | wechat-feeds</title><link>http://MzIwMTk2MDM3Ng.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>林丹瑜教授谈K-M曲线和Cox回归：史上引用次数第11位和24位</title><link>https://mp.weixin.qq.com/s/Icg2S1wRZHTL-QitYWr6Mg</link><description></description><content:encoded><![CDATA[林丹瑜教授谈K-M曲线和Cox回归：史上引用次数第11位和24位]]></content:encoded><pubDate>Wed, 31 Mar 2021 08:30:00 +0800</pubDate></item><item><title>PD-1/PD-L1联合治疗全梳理：理想很丰满，现实很骨感</title><link>https://mp.weixin.qq.com/s/57xnsY3Z85ErmP3aQryvkQ</link><description></description><content:encoded><![CDATA[PD-1/PD-L1联合治疗全梳理：理想很丰满，现实很骨感]]></content:encoded><pubDate>Mon, 29 Mar 2021 10:33:16 +0800</pubDate></item><item><title>晚期食管癌一线治疗：国产PD-1虎视眈眈，K药能坐稳头把交椅吗？</title><link>https://mp.weixin.qq.com/s/d8R0jf0i_2U0oLtFF8irWg</link><description></description><content:encoded><![CDATA[晚期食管癌一线治疗：国产PD-1虎视眈眈，K药能坐稳头把交椅吗？]]></content:encoded><pubDate>Fri, 26 Mar 2021 12:28:01 +0800</pubDate></item><item><title>2021肿瘤新药数据卡——普拉替尼</title><link>https://mp.weixin.qq.com/s/02GOWk4-1jjAR8FK4MkQqA</link><description></description><content:encoded><![CDATA[2021肿瘤新药数据卡——普拉替尼]]></content:encoded><pubDate>Wed, 24 Mar 2021 14:55:35 +0800</pubDate></item><item><title>医药魔方Med招聘：医学编辑</title><link>https://mp.weixin.qq.com/s/C_syBbC4N29Ugy7KQD9niQ</link><description></description><content:encoded><![CDATA[医药魔方Med招聘：医学编辑]]></content:encoded><pubDate>Tue, 23 Mar 2021 12:21:47 +0800</pubDate></item><item><title>循证慢头条：老年乳腺癌患者化疗毒性预测开发新工具，早期支持治疗降低食管胃癌死亡风险达32%</title><link>https://mp.weixin.qq.com/s/Oi45Ah57hJaZbDFZj7KL6g</link><description></description><content:encoded><![CDATA[循证慢头条：老年乳腺癌患者化疗毒性预测开发新工具，早期支持治疗降低食管胃癌死亡风险达32%]]></content:encoded><pubDate>Mon, 22 Mar 2021 16:05:50 +0800</pubDate></item><item><title>2021肿瘤新药数据卡——优替德隆</title><link>https://mp.weixin.qq.com/s/VukLMPlcsa0lctgnumoYqg</link><description></description><content:encoded><![CDATA[2021肿瘤新药数据卡——优替德隆]]></content:encoded><pubDate>Fri, 19 Mar 2021 17:59:14 +0800</pubDate></item><item><title>Tecentriq vs Keytruda：三阴乳腺癌竞争白热化，一图尽览核心临床布局</title><link>https://mp.weixin.qq.com/s/3JB7wd_OkPUuXm2z9-igUQ</link><description></description><content:encoded><![CDATA[Tecentriq vs Keytruda：三阴乳腺癌竞争白热化，一图尽览核心临床布局]]></content:encoded><pubDate>Wed, 17 Mar 2021 12:29:35 +0800</pubDate></item><item><title>靶向c-Met：特泊替尼 vs 卡马替尼 vs 赛沃替尼</title><link>https://mp.weixin.qq.com/s/UmLME0Whleo86QG0kQqmbg</link><description></description><content:encoded><![CDATA[靶向c-Met：特泊替尼 vs 卡马替尼 vs 赛沃替尼]]></content:encoded><pubDate>Mon, 15 Mar 2021 11:05:15 +0800</pubDate></item><item><title>2020肿瘤新药数据卡——氯化镭[223Ra]</title><link>https://mp.weixin.qq.com/s/7OjVoQDQmq4EPosLzROWXw</link><description></description><content:encoded><![CDATA[2020肿瘤新药数据卡——氯化镭[223Ra]]]></content:encoded><pubDate>Fri, 12 Mar 2021 09:40:16 +0800</pubDate></item></channel></rss>